What Researchers Did
Researchers conducted a retrospective study at Alfred Hospital to evaluate the safety and efficacy of hyperbaric oxygen therapy for specific complications following lung transplantation.
What They Found
Among 544 lung transplant recipients, 9 patients (1.7%) received hyperbaric oxygen therapy for complications including sternal osteomyelitis (n=4) and refractory cellulitis (n=2). The treatment was generally well tolerated, with 5 patients experiencing complete resolution of these life-threatening complications, although 2 patients ceased therapy prematurely due to a seizure or ear barotrauma.
What This Means for Canadian Patients
This therapy may offer a safe and useful option for Canadian lung transplant patients experiencing severe infectious or ischemic complications. It could potentially help resolve life-threatening issues and improve long-term outcomes for those who tolerate the treatment.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Australia. However, the findings could inform clinical practice in Canada for similar patient populations.
Study Limitations
The main limitation of this study is its retrospective design and very small sample size of only 9 patients.